EUVIMED · CrossrefJournal
The Lancet Respiratory Medicine
ISSN 2213-2600 · Elsevier BV
Latest articles
Correction to Lancet Respir Med 2024; 12: 281–93
Ending the global neglect of pneumonia: from awareness to accountability
Breathlessness mechanisms, measurement, and management in adults: evidence update on behalf of The Dyspnoea Society
Longitudinal change in FEV1 in adults with cystic fibrosis treated with elexacaftor–tezacaftor–ivacaftor in France: a prospective observational study
Obstructive sleep apnoea: an overlooked challenge in the current NHS Strategy
Consensus on the definition, components, and grading of composite postoperative pulmonary complication outcomes (PrECiSIOn): insights from an international Delphi expert panel
Defining residual lung disease with CFTR modulators
Laennec beyond the stethoscope
RSV multidose vaccine puts Africa's RSV burden in focus
Closing the logic gap—expanding who we consider for tuberculosis treatment
Children are not small adults: CAD for childhood tuberculosis
2027 GOLD COPD report
The present and future of chronic obstructive pulmonary disease prevention, diagnosis, and management in China: a Lancet Respiratory Medicine Commission
Long-term safety and efficacy of twice-yearly depemokimab in type 2 asthma with an eosinophilic phenotype: 2-year integrated analysis of the phase 3a SWIFT-1 and SWIFT-2 studies and AGILE open-label extension
From coverage to equitable reach: addressing social inequalities in COPD in China
Reshaping COPD care in China: bridging geographical divides and empowering health-care workers
Twice-yearly depemokimab: beyond dosing convenience
Prevalence and disease trajectories of pulmonary fibrosis of childhood interstitial lung disease: a register-based, multicentre observational study
Rheumatoid arthritis-associated interstitial lung disease: screening, diagnosis, and treatment—an expert group consensus statement
Sugammadex versus neostigmine for reversal of neuromuscular blockade and postoperative pulmonary complications (SNaPP): an international, randomised, controlled, phase 4 trial
Sugammadex versus neostigmine and postoperative pulmonary complications: a word of caution
Contributors to the heterogeneity of response to CFTR modulators
PERC-Peds rule for bedside exclusion of pulmonary embolism without radiation in children in the USA (BEEPER): a multicentre, prospective, observational, diagnostic accuracy study
Oxygen saturation thresholds in children with acute respiratory distress (OxyKids): a multicentre, open, parallel-group, randomised clinical trial
Asthma exacerbation profile of benralizumab for severe eosinophilic asthma (the BenRex study): a multicentre, prospective cohort study
Challenging dogmata of oxygen therapy in acute childhood illness
Severe asthma and remission prospects in Europe (SHARP): insights from a multicentre observational study based on the European Severe Asthma Registry
The role of sweat chloride in determining CFTR protein restoration in people with cystic fibrosis
Toxic skies of war
Africa's inhaler dilemma: balancing cost, climate, and care
EUVIMED